AbL Diagnostics SA (PA:ABLD) — Stock Price

€2.42 EUR
▼ -2.42% today

AbL Diagnostics SA (PA:ABLD) is currently trading at €2.42 EUR, down 2.42% today. Over the past 52 weeks, shares have ranged between €2.22 and €4.90. This page tracks AbL Diagnostics SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AbL Diagnostics SA market cap and net worth.

AbL Diagnostics SA (ABLD) Stock Price Chart — Daily History & Trading Volume

The chart below tracks AbL Diagnostics SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

AbL Diagnostics SA Income Statement — Revenue, Profit & Earnings by Year

AbL Diagnostics SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €6.95 Million €5.33 Million €5.61 Million €8.75 Million €0.00
Cost of Revenue €327.44K €494.25K €734.53K €426.70K €101.64K
Gross Profit €6.62 Million €4.84 Million €4.88 Million €8.32 Million €-101.64K
Research & Development
SG&A €1.51 Million €1.46 Million €1.37 Million €1.01K
Total Operating Expenses €6.66 Million €5.76 Million €6.23 Million €8.69 Million €988.00
Operating Income €290.50K €-431.14K €-616.65K €59.28K €-102.64K
EBITDA €1.06 Million €295.96K
EBIT €1.07 Million €-102.64K
Interest Expense €73.71K €72.84K €54.12K €12.82K €11.00
Income Before Tax €328.81K €-436.98K €-623.85K €490.52K €-102.61K
Income Tax Expense €-615.15K €38.09K
Net Income €986.70K €285.17K €54.36K €1.11 Million €-140.70K

AbL Diagnostics SA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes AbL Diagnostics SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €12.95 Million €11.81 Million €14.90 Million €15.41 Million €2.71 Million
Total Current Assets €9.43 Million €8.43 Million €11.61 Million €11.99 Million €2.71 Million
Cash & Equivalents €60.54K €90.00 €90.00 €2.70 Million
Short-term Investments €234.36K €60.54K €94.00 €94.00 €94.00
Net Receivables €4.93 Million €3.23 Million €3.97 Million €3.94 Million €10.83K
Inventory €1.14 Million €699.41K €707.38K €665.28K
Property, Plant & Equipment €463.38K €511.04K €826.94K €0.00
Goodwill
Total Liabilities €5.32 Million €4.32 Million €8.14 Million €8.65 Million €94.26K
Total Current Liabilities €3.92 Million €1.76 Million €5.84 Million €6.97 Million €94.26K
Long-term Debt €1.40 Million €2.55 Million €2.30 Million €3.02 Million
Net Debt €1.17 Million €2.08 Million €1.24 Million €2.01 Million €-2.70 Million
Total Stockholder Equity €7.63 Million €7.49 Million €6.77 Million €6.75 Million €2.62 Million
Retained Earnings €2.39 Million €2.25 Million €1.53 Million €1.49 Million €168.57K

AbL Diagnostics SA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how AbL Diagnostics SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €1.51 Million €-1.35 Million €926.43K €-54.25K €-56.69K
Capital Expenditures €792.67K €963.21K €938.50K €1.84 Million €0.00
Free Cash Flow €714.76K €-2.32 Million €-56.69K
Investing Cash Flow €-527.67K €-1.49 Million €400.00K
Financing Cash Flow €813.07K €-142.75K €0.00
Dividends Paid
Stock-Based Compensation
Depreciation €610.34K €757.49K
Change in Cash €787.01K €-1.70 Million €1.21 Million €-1.69 Million €343.31K

AbL Diagnostics SA Earnings History — EPS Actual vs. Analyst Estimates

Track AbL Diagnostics SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 01, 2025 0.00 0.00
May 06, 2025 0.00 0.00
Nov 18, 2024 0.00 0.00
Sep 02, 2022 -0.06 0.00
May 20, 2022 -0.02 0.00
Jul 30, 2021 1.19 0.00
Apr 23, 2021 -0.21 0.00
Sep 10, 2020 -0.15 0.00